Literature DB >> 24145523

Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infection.

Iliana González-Hernández1, Lucinda Aguirre-Cruz, Julio Sotelo, Raquel López-Arellano, Adriana Morales-Hipólito, Helgi Jung-Cook.   

Abstract

Hydroxychloroquine has been proposed for HIV treatment; however, little is known about its disposition in the lymphatic system, where replication takes place. Therefore, its distribution in lymphoid tissues (Peyer's patches and popliteal, submandibular, femoral, splenic, and prescapular lymph nodes) was evaluated and compared with that in blood. Results showed a high affinity of hydroxychloroquine for all of these tissues, with higher affinity for the splenic and submandibular lymph nodes, suggesting its potential use as a coadjuvant in HIV therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145523      PMCID: PMC3910764          DOI: 10.1128/AAC.01440-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Immunomodulatory treatment in patients with rheumatic diseases: mechanisms of action.

Authors:  G C Tsokos
Journal:  Semin Arthritis Rheum       Date:  1987-08       Impact factor: 5.532

2.  Bovine immunodeficiency virus in experimentally infected rabbit: tropism for lymphoid and nonlymphoid tissues.

Authors:  R Walder; L Kalvatchev; F Pérez; D Garzaro; M Barrios
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2001-01       Impact factor: 2.268

3.  Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.

Authors:  David C Warhurst; Jonathan C P Steele; Ipemida S Adagu; John C Craig; Christopher Cullander
Journal:  J Antimicrob Chemother       Date:  2003-07-01       Impact factor: 5.790

4.  Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial.

Authors:  P Clark; E Casas; P Tugwell; C Medina; C Gheno; G Tenorio; J A Orozco
Journal:  Ann Intern Med       Date:  1993-12-01       Impact factor: 25.391

5.  A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.

Authors:  S E Tett; D J Cutler; R O Day; K F Brown
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

6.  Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.

Authors:  Yoko Momose; Satoru Arai; Hikaru Eto; Mitsumasa Kishimoto; Masato Okada
Journal:  J Dermatol       Date:  2012-12-06       Impact factor: 4.005

7.  Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1-infected humans.

Authors:  Ruimin Pan; Jared M Sampson; Yuxin Chen; Michael Vaine; Shixia Wang; Shan Lu; Xiang-Peng Kong
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

8.  Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis.

Authors:  Samantha J Carmichael; Bruce Charles; Susan E Tett
Journal:  Ther Drug Monit       Date:  2003-12       Impact factor: 3.681

9.  Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.

Authors:  K Sperber; T H Kalb; V J Stecher; R Banerjee; L Mayer
Journal:  AIDS Res Hum Retroviruses       Date:  1993-01       Impact factor: 2.205

10.  Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

Authors:  Nicholas I Paton; Ruth L Goodall; David T Dunn; Samuel Franzen; Yolanda Collaco-Moraes; Brian G Gazzard; Ian G Williams; Martin J Fisher; Alan Winston; Julie Fox; Chloe Orkin; Elbushra A Herieka; Jonathan G Ainsworth; Frank A Post; Mark Wansbrough-Jones; Peter Kelleher
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

View more
  2 in total

1.  Influence of quinacrine and chloroquine on the in vitro 3'-azido-3'-deoxythymidine antiretroviral effect.

Authors:  Klintsy J Torres; Gustavo Reyes-Terán; Julio Sotelo; Helgi Jung-Cook; Lucinda Aguirre-Cruz
Journal:  AIDS Res Ther       Date:  2015-03-19       Impact factor: 2.250

2.  Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.

Authors:  Immacolata Faraone; Fabiana Labanca; Maria Ponticelli; Nunziatina De Tommasi; Luigi Milella
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.